Matxalen Vidal-Garcia
Overview
Explore the profile of Matxalen Vidal-Garcia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urrutikoetxea-Gutierrez M, Gual-de-Torrella A, Vidal-Garcia M, Berdonces Gonzalez P
Enferm Infecc Microbiol Clin (Engl Ed)
. 2024 Jun;
42(8):462-463.
PMID: 38902153
No abstract available.
2.
Vidal-Garcia M, Urrutikoetxea-Gutierrez M, Forero Niampira J, Basaras M, Cisterna R, Diaz de Tuesta Del Arco J
Future Microbiol
. 2023 Oct;
18:1309-1317.
PMID: 37850345
This study aimed to assess the ultra-fast method using MinION™ sequencing for rapid identification of β-lactamase-producing clinical isolates from positive blood cultures. Spiked-blood positive blood cultures were extracted using the...
3.
Quindos G, Miranda-Cadena K, San-Millan R, Borroto-Esoda K, Canton E, Linares-Sicilia M, et al.
Front Cell Infect Microbiol
. 2022 Jun;
12:906563.
PMID: 35651755
Background: Ibrexafungerp (SCY-078) is the newest oral and intravenous antifungal drug with broad activity, currently undergoing clinical trials for invasive candidiasis. Objective: The aim of this study was to assess...
4.
Urrutikoetxea-Gutierrez M, Sanchez Montiel M, Vidal-Garcia M, Basaras M, Cisterna Cancer R, Diaz de Tuesta Del Arco J
Future Microbiol
. 2021 Nov;
16:1381-1387.
PMID: 34809469
Fast diagnosis of bloodstream infections remains the most important challenge for clinical microbiologists. The introduction of the mass-spectrometry represents a breakthrough, although several methods are already commonly used for the...
5.
Xanthopoulou K, Urrutikoetxea-Gutierrez M, Vidal-Garcia M, Diaz de Tuesta Del Arco J, Sanchez-Urtaza S, Wille J, et al.
Front Microbiol
. 2020 Nov;
11:589253.
PMID: 33240245
The objective of this study was the phenotypic and genotypic characterization of a carbapenem resistant (CRAB) isolate. The isolate, recovered in Northern Spain in 2019, was identified by MALDI-TOF to...
6.
Arias M, Santiago L, Vidal-Garcia M, Redrado S, Lanuza P, Comas L, et al.
Front Immunol
. 2018 Nov;
9:2549.
PMID: 30459771
Pulmonary aspergillosis is a severe infectious disease caused by some members of the genus, that affects immunocompetent as well as immunocompromised patients. Among the different disease forms, Invasive Aspergillosis is...
7.
Vidal-Garcia M, Redrado S, Domingo M, Marquina P, Colmenarejo C, Meis J, et al.
Front Microbiol
. 2018 Jun;
9:1246.
PMID: 29946309
Gliotoxin (GT) is a fungal secondary metabolite that has attracted great interest due to its high biological activity since it was discovered by the 1930s. An inactive derivative of this...
8.
Nieto A, Pozo F, Vidal-Garcia M, Omenaca M, Casas I, Falcon A
Front Microbiol
. 2017 Jun;
8:1080.
PMID: 28626458
[This corrects the article on p. 575 in vol. 8, PMID: 28421062.].
9.
Nieto A, Pozo F, Vidal-Garcia M, Omenaca M, Casas I, Falcon A
Front Microbiol
. 2017 Apr;
8:575.
PMID: 28421062
Several amino acid changes have been previously implicated in adaptation of avian influenza viruses to human hosts, among them the D701N change in the PB2 polymerase subunit that also is...
10.
Vidal-Garcia M, Sanchez-Chueca P, Domingo M, Ballester C, Roc L, Ferrer I, et al.
Rev Iberoam Micol
. 2016 Dec;
34(1):49-52.
PMID: 27939578
Background: Disseminated invasive aspergillosis is an exceptional finding in immunocompetent hosts. As in immunocompromised patients, it has high mortality rates. Early diagnostic methods are required in order to properly manage...